Bruker Corp (BRKR) Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Bruker Corp (NASDAQ: BRKR) FY 2026 Product Release
18 articles, transcripts, and reports
Bruker Corp (NASDAQ: BRKR) FY 2026 Product Release
Bruker Corp (NASDAQ: BRKR) Q2 2025 Earnings Call dated Aug. 04, 2025 Corporate Participants: Joe Kostka — Director, Investor Relations Frank H. Laukien — President…
Bruker Corp (NASDAQ: BRKR) Q3 2025 Earnings Call dated Nov. 03, 2025 Corporate Participants: Joe Kostka — Director, Investor Relations Frank H. Laukien — Chairman,…
Bruker Corp (NASDAQ: BRKR) Q2 2022 Earnings Conference
Bruker Corp (NASDAQ: BRKR) Q1 2022 Earnings Conference
Bruker Corp (NASDAQ: BRKR) Q4 2021 Earnings Conference
Bruker Corp (NASDAQ: BRKR) Q3 2021 Earnings Conference
Bruker Corp (NASDAQ: BRKR) Q2 2021 Earnings Conference